Dry Eye Disease Treatment: A Systematic Review of Published Trials and a Critical Appraisal of Therapeutic Strategies
Tài liệu tham khảo
(No authors listed), 2007, The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007), Ocul Surf, 5, 75, 10.1016/S1542-0124(12)70081-2
(No authors listed), 2007, The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007), Ocul Surf, 5, 93, 10.1016/S1542-0124(12)70082-4
Lee, 2002, Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia, Br J Ophthalmol, 86, 1347, 10.1136/bjo.86.12.1347
Moss, 2004, Incidence of dry eye in an older population, Arch Ophthalmol, 122, 369, 10.1001/archopht.122.3.369
Odeh, 2007, Relationship between circulating levels of tumour necrosis factor-alpha and Child-Pugh scores in liver cirrhosis, Int J Clin Pract, 61, 519, 10.1111/j.1742-1241.2006.01233.x
Marsh, 1999, Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome, Ophthalmology, 106, 811, 10.1016/S0161-6420(99)90171-9
Rosenberg, 2010, Essential fatty acids in the treatment of dry eye, Ocul Surf, 8, 18, 10.1016/S1542-0124(12)70214-8
Sullivan, 1999, Androgens and dry eye in Sjogren's syndrome, Ann N Y Acad Sci, 876, 312, 10.1111/j.1749-6632.1999.tb07656.x
Cade-Jorge, 2009, Perspectives in therapeutic innovation in ocular surface disorders and dry eye syndrome, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 3, 194, 10.2174/187221409789104782
Asbell, 2010, Ophthalmologist perceptions regarding treatment of moderate-to-severe dry eye: results of a physician survey, Eye Contact Lens, 36, 33, 10.1097/ICL.0b013e3181c739ad
Doughty, 2009, Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review, Ophthalmic Physiol Opt, 29, 573, 10.1111/j.1475-1313.2009.00683.x
Akpek EK, Lindsley KB, Adyanthaya RS, et al. Treatment of Sjogren's syndrome-associated dry eye: an evidence-based review. Ophthalmology 118:1242–52
Ramos-Casals, 2010, Treatment of primary Sjogren syndrome: a systematic review, JAMA, 304, 452, 10.1001/jama.2010.1014
Horton, 2006, Trial registers: protecting patients, advancing trust, Lancet, 367, 1633, 10.1016/S0140-6736(06)68709-6
Schiffman, 2000, Reliability and validity of the Ocular Surface Disease Index, Arch Ophthalmol, 118, 615, 10.1001/archopht.118.5.615
Nichols, 2002, Performance and repeatability of the NEI-VFQ-25 in patients with dry eye, Cornea, 21, 578, 10.1097/00003226-200208000-00009
Chalmers, 1993, The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care, Ann N Y Acad Sci, 703, 156, 10.1111/j.1749-6632.1993.tb26345.x
Shin, 2010, Acupuncture for treating dry eye: a randomized placebo-controlled trial, Acta Ophthalmol, 88, e328, 10.1111/j.1755-3768.2010.02027.x
Tseng, 2006, A clinical study of acupuncture and SSP (silver spike point) electro-therapy for dry eye syndrome, Am J Chin Med, 34, 197, 10.1142/S0192415X0600376X
Lee, 2011, Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease, Cornea, 30, 175, 10.1097/ICO.0b013e3181e9adcc
Rolando, 2009, Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients, J Ocul Pharmacol Ther, 25, 271, 10.1089/jop.2008.0026
Johnson, 2008, Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment, Optom Vis Sci, 85, 750, 10.1097/OPX.0b013e318182476c
Christensen, 2008, Corneal staining reductions observed after treatment with Systane Lubricant Eye Drops, Adv Ther, 25, 1191, 10.1007/s12325-008-0112-0
Khanal, 2007, Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye, Cornea, 26, 175, 10.1097/ICO.0b013e31802b492d
Chiambaretta, 2004, [Efficacy and safety of a fluid carbomer gel versus a conventional carbomer gel in dry eye treatment], J Fr Ophtalmol, 27, 130, 10.1016/S0181-5512(04)96106-2
Christensen, 2004, Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye, Curr Eye Res, 28, 55, 10.1076/ceyr.28.1.55.23495
Aragona, 2002, Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye, Br J Ophthalmol, 86, 181, 10.1136/bjo.86.2.181
Nepp, 2001, The clinical use of viscoelastic artificial tears and sodium chloride in dry-eye syndrome, Biomaterials, 22, 3305, 10.1016/S0142-9612(01)00167-3
Iester, 2000, Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca, Eye (Lond), 14, 892, 10.1038/eye.2000.244
Bron, 1998, Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears, Eye (Lond), 12, 839, 10.1038/eye.1998.215
Grene, 1992, Unpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis sicca, Cornea, 11, 294, 10.1097/00003226-199207000-00004
Gobbels, 1991, Effects of artificial tears on corneal epithelial permeability in dry eyes, Graefes Arch Clin Exp Ophthalmol, 229, 345, 10.1007/BF00170693
Nelson, 1988, Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca, Arch Ophthalmol, 106, 484, 10.1001/archopht.1988.01060130530029
Noda-Tsuruya, 2006, Autologous serum eye drops for dry eye after LASIK, J Refract Surg, 22, 61, 10.3928/1081-597X-20060101-13
Kojima, 2005, The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study, Am J Ophthalmol, 139, 242, 10.1016/j.ajo.2004.08.040
Pflugfelder, 2004, A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance, Am J Ophthalmol, 138, 444, 10.1016/j.ajo.2004.04.052
Chen, 2010, A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial, J Ocul Pharmacol Ther, 26, 361, 10.1089/jop.2009.0145
Baiza-Durán, 2010, A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome, Br J Ophthalmol, 94, 1312, 10.1136/bjo.2008.150011
Kim, 2009, A comparison of vitamin A and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome, Am J Ophthalmol, 147, 206, 10.1016/j.ajo.2008.08.015
Willen, 2008, Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes, Eye Contact Lens, 34, 43, 10.1097/ICL.0b013e3180676d44
Roberts, 2007, Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye, Cornea, 26, 805, 10.1097/ICO.0b013e318074e460
Salib, 2006, Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis, J Cataract Refract Surg, 32, 772, 10.1016/j.jcrs.2005.10.034
Sall, 2000, Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group, Ophthalmology, 107, 631, 10.1016/S0161-6420(99)00176-1
Stevenson, 2000, Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group, Ophthalmology, 107, 967, 10.1016/S0161-6420(00)00035-X
Sall, 2006, An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye, Eye Contact Lens, 32, 21, 10.1097/01.icl.0000170599.57728.29
Gunduz, 1994, Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren's syndrome, Acta Ophthalmol (Copenh), 72, 438, 10.1111/j.1755-3768.1994.tb02792.x
Tauber, 2004, Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye, Cornea, 23, 784, 10.1097/01.ico.0000133993.14768.a9
Aragona, 2005, Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients, Eye (Lond), 19, 535, 10.1038/sj.eye.6701537
Avisar, 2000, Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis, Cornea, 19, 145, 10.1097/00003226-200003000-00005
Petrone, 2002, A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca, Arthritis Rheum, 46, 748, 10.1002/art.510
Creuzot, 2006, [Improvement of dry eye symptoms with polyunsaturated fatty acids], J Fr Ophtalmol, 29, 868, 10.1016/S0181-5512(06)70106-1
Pinheiro, 2007, [Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögren's syndrome patients], Arq Bras Oftalmol, 70, 649
Barabino, 2003, Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component, Cornea, 22, 97, 10.1097/00003226-200303000-00002
Papas, 2004, Successful treatment of dry mouth and dry eye symptoms in Sjögren's syndrome patients with oral pilocarpine: A randomized, placebo-controlled, dose-adjustment study, J Clin Rheumatol, 10, 169, 10.1097/01.rhu.0000135553.08057.21
Tsifetaki, 2003, Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study, Ann Rheum Dis, 62, 1204, 10.1136/ard.2002.003889
Vivino, 1999, Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group, Arch Intern Med, 159, 174, 10.1001/archinte.159.2.174
Burgess, 2008, SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial, Cornea, 27, 391, 10.1097/ICO.0b013e318160d030
Nava-Castaneda, 2003, Effects of lacrimal occlusion with collagen and silicone plugs on patients with conjunctivitis associated with dry eye, Cornea, 22, 10, 10.1097/00003226-200301000-00003
Farrell, 2003, A clinical procedure to predict the value of temporary occlusion therapy in keratoconjunctivitis sicca, Ophthalmic Physiol Opt, 23, 1, 10.1046/j.1475-1313.2003.00081.x
(No authors listed), 2007, Design and conduct of clinical trials: report of the Clinical Trials Subcommittee of the International Dry Eye WorkShop (2007), Ocul Surf, 5, 153, 10.1016/S1542-0124(12)70084-8
Baffa Ldo, 2008, Tear film and ocular surface alterations in chronic users of antiglaucoma medications, Arq Bras Oftalmol, 71, 18, 10.1590/S0004-27492008000100004
Sankar, 2004, Etanercept in Sjogren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial, Arthritis Rheum, 50, 2240, 10.1002/art.20299
Koffler, 2010, Improved signs, symptoms, and quality of life associated with dry eye syndrome: hydroxypropyl cellulose ophthalmic insert patient registry, Eye Contact Lens, 36, 170, 10.1097/ICL.0b013e3181db352f
Uchiyama, 2008, Impact on ocular surface evaporation of an artificial tear solution containing hydroxypropyl guar, Eye Contact Lens, 34, 331, 10.1097/ICL.0b013e31818c66b5
Ridder, 2009, Contrast sensitivity and tear layer aberrometry in dry eye patients, Optom Vis Sci, 86, E1059, 10.1097/OPX.0b013e3181b599bf
Schechter, 2006, Ketorolac during the induction phase of cyclosporin-A therapy, J Ocul Pharmacol Ther, 22, 150, 10.1089/jop.2006.22.150
Willeke, 2007, Mycophenolate sodium treatment in patients with primary Sjogren syndrome: a pilot trial, Arthritis Res Ther, 9, R115, 10.1186/ar2322
Kaufman, 1994, Collagen-based drug delivery and artificial tears, J Ocul Pharmacol, 10, 17, 10.1089/jop.1994.10.17
Lodde, 2006, Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment, Ann Rheum Dis, 65, 1406, 10.1136/ard.2006.052761
Frank, 2003, New estimates of drug development costs, J Health Econ, 22, 325, 10.1016/S0167-6296(03)00002-X
Novack, 2008, Conducting clinical trials: even more challenges, Ocul Surf, 6, 99, 10.1016/S1542-0124(12)70275-6
Moore, 2009, Concordance between common dry eye diagnostic tests, Br J Ophthalmol, 93, 66, 10.1136/bjo.2007.131722
Novack, 2002, Pharmacologic treatments for dry eye: a worthwhile investment?, Cornea, 21, 4, 10.1097/00003226-200201000-00002